171 related articles for article (PubMed ID: 26062811)
1. Filling the gap in central shielding: three-dimensional analysis of the EQD2 dose in radiotherapy for cervical cancer with the central shielding technique.
Tamaki T; Ohno T; Noda SE; Kato S; Nakano T
J Radiat Res; 2015 Sep; 56(5):804-10. PubMed ID: 26062811
[TBL] [Abstract][Full Text] [Related]
2. Dose-volume histogram analysis of composite EQD2 dose distributions using the central shielding technique in cervical cancer radiotherapy.
Tamaki T; Noda SE; Ohno T; Kumazaki Y; Kato S; Nakano T
Brachytherapy; 2016; 15(5):598-606. PubMed ID: 27475482
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of three-dimensional conformal radiotherapy versus volumetric-arc radiotherapy in cervical cancer treatment: applying the central-shielding principle to modern technology.
Tamaki T; Hirai R; Igari M; Kumazaki Y; Noda SE; Suzuki Y; Kato S
J Radiat Res; 2018 Sep; 59(5):639-648. PubMed ID: 30053184
[TBL] [Abstract][Full Text] [Related]
4. Assessing cumulative dose distributions in combined radiotherapy for cervical cancer using deformable image registration with pre-imaging preparations.
Abe T; Tamaki T; Makino S; Ebara T; Hirai R; Miyaura K; Kumazaki Y; Ohno T; Shikama N; Nakano T; Kato S
Radiat Oncol; 2014 Dec; 9():293. PubMed ID: 25526986
[TBL] [Abstract][Full Text] [Related]
5. [Dosimetric analysis of radiotherapy with middle shielding blocks of different widths at the lower cervical supraclavicular field for stage N2-3 nasopharyngeal carcinoma].
Li FM; Luo W; He ZC; Zhang L; Sun Y; Qin WJ; Lu LX; Han F; Liu XQ; Liu MZ
Ai Zheng; 2007 Oct; 26(10):1127-32. PubMed ID: 17927886
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract][Full Text] [Related]
7. Rotating-shield brachytherapy for cervical cancer.
Yang W; Kim Y; Wu X; Song Q; Liu Y; Bhatia SK; Sun W; Flynn RT
Phys Med Biol; 2013 Jun; 58(11):3931-41. PubMed ID: 23680601
[TBL] [Abstract][Full Text] [Related]
8. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
[TBL] [Abstract][Full Text] [Related]
9. The effect of central shielding in the dose reporting for cervical cancer in EQD2 era.
Tharavichitkul E; Wanwilairat S; Watcharawipha A; Tippanya D; Jayasvasti R; Chakrabandhu S; Klunklin P; Onchan W; Galalae R; Chitapanarux I
J Contemp Brachytherapy; 2013 Dec; 5(4):236-9. PubMed ID: 24474974
[TBL] [Abstract][Full Text] [Related]
10. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
[TBL] [Abstract][Full Text] [Related]
11. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
[TBL] [Abstract][Full Text] [Related]
12. The equivalent dose contribution from high-dose-rate brachytherapy to positive pelvic lymph nodes in locally advanced cervical cancer.
Lee YC; Rash DL; Stern RL; Mayadev JS
Brachytherapy; 2013; 12(6):555-9. PubMed ID: 23880417
[TBL] [Abstract][Full Text] [Related]
13. Retrospective DVH analysis of point A based intracavitary brachytherapy for uterine cervical cancer.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Gocho T; Fukushima Y; Hori M; Miura K; Takada Y; Nakata K; Sakata KI
J Radiat Res; 2020 Mar; 61(2):265-274. PubMed ID: 32009177
[TBL] [Abstract][Full Text] [Related]
14. Impact of different dose prescription schedules on EQD
Kumar M; Thangaraj R; Alva RC; Koushik K; Ponni A; Achar JM
J Contemp Brachytherapy; 2019 Apr; 11(2):189-193. PubMed ID: 31139229
[TBL] [Abstract][Full Text] [Related]
15. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
[TBL] [Abstract][Full Text] [Related]
16. Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.
Hirai R; Tamaki T; Igari M; Kumazaki YU; Noda SE; Kato S
In Vivo; 2020; 34(6):3611-3618. PubMed ID: 33144475
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.
Mukai Y; Minagawa Y; Inoue H; Sato A; Matsui K; Fukuda T; Onuma K; Hongo H; Shirata R; Nagata H; Hashimoto H; Inoue T; Hata M; Omura M
In Vivo; 2020; 34(6):3387-3398. PubMed ID: 33144446
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the total rectal dose of radical external beam and intracavitary radiotherapy for uterine cervical cancer using the deformable image registration method.
Hayashi K; Isohashi F; Akino Y; Wakai N; Mabuchi S; Suzuki O; Seo Y; Ootani Y; Sumida I; Yoshioka Y; Kimura T; Ogawa K
J Radiat Res; 2015 May; 56(3):546-52. PubMed ID: 25678538
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
